Drug Type Prophylactic vaccine |
Synonyms Influenza A vaccine H5N1, Influenza A vaccine intranasal, Influenza-virus-vaccine-Vaxin + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | US | 10 Oct 2020 | |
Influenza, Human | Phase 2 | US | 18 Sep 2017 |
Phase 2 | 48 | (NasoVAX) | soagpjqtpt(rrugarepsd) = axjnwjjfcb bazqdmwazx (bwyjbuiwvp, rygmpqtnot - juwokjysua) View more | - | 04 Apr 2022 | ||
Placebo (Placebo) | soagpjqtpt(rrugarepsd) = drkfhccfiu bazqdmwazx (bwyjbuiwvp, iopzcitrrm - tlhodrcuyl) View more | ||||||
Phase 2 | 60 | (NasoVAX Low Dose) | qdbvyparqr(tpiaqjdaqx) = ulcnikonxo ihvslndvkp (ppdztwgkme, jvdibzhikc - wnubyobkwd) View more | - | 11 Apr 2019 | ||
(NasoVAX Medium Dose) | qdbvyparqr(tpiaqjdaqx) = jywwfmzqvb ihvslndvkp (ppdztwgkme, himphprfle - cmdgclfjdl) View more |